Characterizing the Patient Experience During the Prodrome Phase of Migraine: A Qualitative Study of Symptoms and Their Timing

被引：0
|
作者：
Stokes, J. [1 ]
Lipton, R. [2 ]
Evans, C. [3 ]
Hribal, E. [3 ]
White, K. [3 ]
Keyloun, K. [1 ]
Parikh, K. [4 ]
Gandhi, P. [1 ]
Dodick, D. [5 ]
机构：
[1] AbbVie, Madison, NJ USA
[2] Albert Einstein Coll Med, Bronx, NY USA
[3] Endpoint Outcomes, Boston, MA USA
[4] AbbVie, N Chicago, IL USA
[5] Mayo Clin, Phoenix, AZ USA
来源：
HEADACHE | 2023年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-34
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [1] Characterizing the Patient Experience During the Prodrome Phase of Migraine: A Qualitative Study of Symptoms and Their Timing
    Stokes, Jonathan
    Lipton, Richard B.
    Evans, Christopher
    Hribal, Elizabeth
    White, Kailee
    Keyloun, Katelyn
    Parikh, Krutika
    Gandhi, Pranav
    Dodick, David W.
    [J]. NEUROLOGY, 2023, 100 (17)
  • [2] Efficacy of Ubrogepant for the Treatment of Migraine Symptoms During the Prodrome (Premonitory Phase): Results From the PRODROME Trial
    Goadsby, Peter J.
    Ailani, Jessica
    Dodick, David W.
    Starling, Amaal J.
    Liu, Chengcheng
    Yu, Sung Yun
    Brand-Schieber, Elimor
    Finnegan, Michelle
    Trugman, Joel M.
    [J]. NEUROLOGY, 2023, 100 (17)
  • [3] Efficacy of ubrogepant for the treatment of migraine symptoms during the prodrome (premonitory phase): results from the PRODROME trial
    Goadsby, P. J.
    Ailani, J.
    Dodick, D. W.
    Starling, A. J.
    Liu, C.
    Yu, S. Y.
    Brand-Schieber, E.
    Finnegan, M.
    Trugman, J. M.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [4] Efficacy of ubrogepant for the treatment of migraine symptoms during the prodrome (premonitory phase): Results from the prodrome trial
    Goadsby, Peter
    Ailani, Jessica
    Dodick, David
    Starling, Amaal
    Davidovic, Goran
    Liu, Chengcheng
    Yun, Yu Sung
    Brand-Schieber, Elimor
    Finnegan, Michelle
    Trugman, Joel
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [5] Efficacy of Ubrogepant for the Treatment of Migraine Symptoms During the Prodrome (Premonitory Phase): Results From the PRODROME Trial
    Goadsby, P.
    Ailani, J.
    Dodick, D.
    Starling, A.
    Liu, C.
    Yu, S.
    Brand-Schieber, E.
    Finnegan, M.
    Trugman, J.
    [J]. HEADACHE, 2023, 63 : 137 - 137
  • [6] Characterizing Prodrome (Premonitory Phase) in Migraine: Results From the PRODROME Trial Screening Period
    Schwedt, Todd J.
    Lipton, Richard B.
    Goadsby, Peter J.
    Chiang, Chia-Chun
    Klein, Brad
    Liu, Chengcheng
    Yu, Sung Yun
    Severt, Lawrence
    Finnegan, Michelle
    Trugman, Joel M.
    [J]. NEUROLOGY, 2023, 100 (17)
  • [7] Characterizing Prodrome (Premonitory Phase) in Migraine: Results From the PRODROME Trial Screening Period
    Schwedt, T.
    Lipton, R.
    Goadsby, P.
    Chiang, C.
    Klein, B.
    Liu, C.
    Yu, S.
    Severt, L.
    Finnegan, M.
    Trugman, J.
    [J]. HEADACHE, 2023, 63 : 119 - 119
  • [8] Characterizing the Patient Experience during Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: A Qualitative Study
    Brown, Zachary J.
    Stevens, Lena
    Monsour, Christina
    Zeh, Ryan
    Sarna, Angela
    Pawlik, Timothy M.
    Ejaz, Aslam
    Cloyd, Jordan
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 441 - 441
  • [9] Characterizing the patient experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma: A qualitative study
    Stevens, Lena
    Brown, Zachary J.
    Zeh, Ryan
    Monsour, Christina
    Wells-Di Gregorio, Sharla
    Santry, Heena
    Ejaz, Aslam M.
    Pawlik, Timothy Michael
    Cloyd, Jordan M.
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (06) : 1175 - 1186
  • [10] Characterizing the patient experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma: A qualitative study
    Lena Stevens
    Zachary J Brown
    Ryan Zeh
    Christina Monsour
    Sharla Wells-Di Gregorio
    Heena Santry
    Aslam M Ejaz
    Timothy Michael Pawlik
    Jordan M Cloyd
    [J]. World Journal of Gastrointestinal Oncology, 2022, (06) : 1175 - 1186
12345